Hillevax

Hillevax EV/EBIT

Delisted

The EV/EBIT (Enterprise Value to EBIT) of Hillevax (HLVX) as of Nov 20, 2026 is -0.67. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -0.79 — a change of -14.13% (higher).

EV/EBIT

-0.67

YoY

-14.13%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Hillevax is 2024 -0.67 . EV/EBIT (Enterprise Value to EBIT) of Hillevax was 2023 -0.79 . It decreases by -14.13% higher compared to the previous year.

The Hillevax EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
-165.55 USD
Jan 1, 2020
-80.92 USD
Jan 1, 2021
-1.96 USD
Jan 1, 2022
-1.61 USD
Jan 1, 2023
-0.79 USD
Jan 1, 2024
-0.67 USD
Jan 1, 2025 (e)
-3.29 USD
Jan 1, 2026 (e)
-3.26 USD
The Hillevax EV/EBIT history
YEAREV/EBITYoY
est-3.26-0.91%
est-3.29+387.55%
-0.67-14.13%
-0.79-51.17%
-1.61-17.95%
-1.96-97.58%
-80.92-51.12%
-165.55—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hillevax Stock analysis

What does Hillevax do? HilleVax, Inc. develops and commercializes novel vaccines, focusing on HIL-214, a bivalent virus-like particle (VLP) vaccine candidate for norovirus-induced acute gastroenteritis. The vaccine combines VLPs for norovirus genotypes GI.1 and GII.4 with an aluminum hydroxide adjuvant to enhance immune response. HIL-214 targets moderate-to-severe cases of norovirus infection, which causes symptoms like diarrhea, vomiting, and dehydration. The company's primary revenue stream will come from the future commercialization of HIL-214 after regulatory approval, with potential sales to healthcare providers and public health programs. Hillevax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hillevax stock

EV/EBIT (Enterprise Value to EBIT) of Hillevax is -0.67 in 2024.

EV/EBIT (Enterprise Value to EBIT) of Hillevax changed from -0.79 to -0.67, representing a -14.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Hillevax since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Hillevax with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Hillevax

All Key Metrics — Hillevax